Monday
09:00 - 15:35
Joslin Hall

Moving beyond the standard: tailoring care in diabetes and obesity

ADVANCING INSULIN INNOVATION FOR PEOPLE WITH DIABETES

John Cunningham (UK) and Juris J Meier (Germany)
Welcome and introduction
Athena Philis-Tsimikas (USA), Lena Landstedt-Hallin (Sweden)
Why should hypoglycaemia be a compromise?
Liana Billings (USA)
Durability of a dual approach
Stephen C Bain (UK)
Intensified insulin management around mealtimes
Athena Philis-Tsimikas (USA), Lena Landstedt-Hallin (Sweden), Liana Billings (USA), Stephen C Bain (UK)
Practical steps for insulin intensification
Richard Bergenstal (USA)
Keynote: Glucose management beyond HbA1c

OPTIMISING THE USE OF GLP-1RAS IN PEOPLE WITH TYPE 2 DIABETES

John Cunningham (UK) and Juris J Meier (Germany)
Welcome back
Rory McCrimmon (UK)
Treatment intensification with semaglutide OW
Marc Evans (UK)
Real-world evidence in type 2 diabetes care
Subodh Verma (Canada)
Clinical implications of evidence from cardiovascular outcomes trials
Rory McCrimmon (UK), Marc Evans (UK), Subodh Verma (Canada)
Clinical aspects of use of GLP-1RAs

OPTIMISING THE USE OF GLP-1RAS IN PEOPLE WITH OBESITY

John Cunningham (UK) and Juris J Meier (Germany)
Welcome back
Thomas Wadden (UK)
The role of IBT in weight management
Ofri Mosenzon (Israel)
Weight management in people with type 2 diabetes on insulin
Thomas Wadden (UK), Ofri Mosenzon (Israel)
Integrating weight management into type 2 diabetes care

FUTURE PERSPECTIVES FOR TYPE 2 DIABETES CARE

John Cunningham (UK) and Juris J Meier (Germany)
Welcome back
Melanie Davies (UK)
Oral GLP-1RAs – a new approach to diabetes treatment (not marketed in Spain)
Vanita Aroda (USA)
Evaluating clinical relevance of an oral GLP-1RA in different populations
Melanie Davies (UK), Vanita Aroda (USA)
Patient-centered decision making
John Cunningham (UK) and Juris J Meier (Germany)
Close of the day
Symposium by: